News|Articles|June 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-06-02-2018
  • Volume 42
  • Issue 6

A Study of the Effects of Histogram Binning on the Accuracy and Precision of Particle Sizing Measurements

Author(s)Eric Olson

This paper analyzes the effectiveness of histogram binning for representing particle-sizing measurements with accuracy and precision.

This work and derivation yielded two equations of note for a geometrically spaced histogram, one for the binning constant, cb, and one for the number of bins, k. With these equations, a conservative histogram may be constructed that has minimal effect on the accuracy and peak width of a number-weighted particle size distribution. Examples including a standard reference material and a real sample are given to show the effects of using these equations. Additionally, a sample of randomly distributed values is also analyzed, both with a traditional algorithm that lead to a discontinuous, discrete distribution, an effect known as over-binning, and the proposed equations, which lead to a continuous distribution.

Click

to view a PDF of this article.

Peer-Reviewed

Submitted: March 5, 2018
Accepted: April 13, 2018

About the Author

Eric Olson is a senior research scientist-Physical and Chemical Characterization at PPD Laboratories.

Article Details

Pharmaceutical Technology
Vol. 42, No. 6
June 2018
Pages: 28–33

Citation

When referring to this article, please cite it as E. Olson, “A Study of the Effects of Histogram Binning on the Accuracy and Precision of Particle Sizing Measurements,” Pharmaceutical Technology 42 (6) 2018.


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.